当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 资产负债表

尔康制药

(300267)

  

流通市值:38.40亿  总市值:55.69亿
流通股本:14.22亿   总股本:20.63亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金501,644,600.73544,929,019.53539,803,972.59764,668,954.42
应收票据及应收账款119,305,797.65144,028,020.42166,139,425.22159,327,132.52
其中:应收票据2,123,784.8413,153,846.3231,420,161.0825,633,906.76
应收账款117,182,012.81130,874,174.1134,719,264.14133,693,225.76
应收款项融资31,659,024.1134,496,950.9414,019,469.345,153,513.74
预付款项151,051,645.0954,018,159.57111,049,444.0284,331,484.8
其他应收款合计9,194,301.2410,858,647.748,168,777.6227,812,555.45
存货731,119,490.7829,667,552.54853,416,396.16821,344,937.88
其他流动资产150,982,900.98130,773,310.72169,577,287.7574,449,061.22
流动资产平衡项目0000
流动资产合计1,694,957,760.51,758,508,679.431,863,153,004.682,091,204,367.56
非流动资产:
长期股权投资124,736,149.08125,321,624.33125,594,266.48138,967,617.7
其他权益工具投资50,000,00050,000,00050,000,00050,000,000
投资性房地产82,089,422.8282,890,792.6684,415,328.1985,263,396.37
固定资产2,618,286,470.722,625,146,735.982,626,353,229.442,681,709,078.72
在建工程214,146,482.42171,687,828.4868,554,391.652,917,026.92
使用权资产120,709,206.06122,734,246.8119,134,016.86121,921,283.08
无形资产384,880,206.28391,204,164.69400,926,526.85406,135,835.57
商誉10,008,171.5410,008,171.5410,008,171.5410,008,171.54
长期待摊费用16,717,517.0317,813,615.718,419,400.5519,495,426.32
递延所得税资产161,868,592.29165,013,515.53169,328,656.61168,703,753.79
其他非流动资产45,996,589.1364,427,742.0264,450,772.0129,333,425.39
非流动资产平衡项目0000
非流动资产合计3,829,438,807.373,826,248,437.733,737,184,760.133,764,455,015.4
资产平衡项目0000
资产总计5,524,396,567.875,584,757,117.165,600,337,764.815,855,659,382.96
流动负债:
短期借款149,000,000149,000,000199,000,000396,641,418.8
应付票据及应付账款139,031,294.34165,324,874.27169,703,383.03198,704,854.89
应付账款139,031,294.34165,324,874.27169,703,383.03198,704,854.89
合同负债36,927,705.7832,911,358.6334,510,835.8551,305,078.84
应付职工薪酬10,342,152.1110,529,211.0511,580,175.2121,406,344.63
应交税费14,450,624.6618,970,106.2413,295,360.523,692,904.48
其他应付款合计31,902,980.8732,921,270.6337,786,855.3443,346,018.09
一年内到期的非流动负债2,082,826.32,245,987.583,453,920.324,108,752.26
其他流动负债4,639,049.094,181,065.584,474,212.176,227,898.45
流动负债平衡项目0000
流动负债合计388,376,633.15416,083,873.98473,804,742.44725,433,270.44
非流动负债:
租赁负债1,146,461.311,628,650.232,105,277.292,576,406.73
递延收益18,570,895.5819,968,091.0121,558,286.3423,148,481.71
递延所得税负债49,499,411.6552,622,690.4854,164,535.6553,410,046.5
非流动负债平衡项目0000
非流动负债合计69,216,768.5474,219,431.7277,828,099.2879,134,934.94
负债平衡项目0000
负债合计457,593,401.69490,303,305.7551,632,841.72804,568,205.38
所有者权益(或股东权益):
实收资本(或股本)2,062,604,8702,062,604,8702,062,604,8702,062,604,870
资本公积1,005,421,601.151,005,421,601.151,005,421,601.151,005,421,601.15
其他综合收益100,922,677.44111,193,268.9224,846,972.0447,428,699.13
专项储备674,996.69807,008.37886,828.72912,498.2
盈余公积129,884,442.27129,884,442.27129,884,442.27129,884,442.27
未分配利润1,782,764,457.841,794,641,121.481,830,647,457.131,804,568,511.5
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,082,273,045.395,104,552,312.195,054,292,171.315,050,820,622.25
少数股东权益-15,469,879.21-10,098,500.73-5,587,248.22270,555.33
股东权益平衡项目0000
股东权益合计5,066,803,166.185,094,453,811.465,048,704,923.095,051,091,177.58
负债和股东权益合计5,524,396,567.875,584,757,117.165,600,337,764.815,855,659,382.96
公告日期2023-10-232023-08-282023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑